![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Efficacy and Safety of Daclatasvir (DCV) in Combination With Asunaprevir (ASV) in Cirrhotic and Non-Cirrhotic Patients With Hepatitis C Virus (HCV) Genotype 1b Infection
|
|
|
Reported by Jules Levin
The 2014 Annual Meeting of the Asian Pacific Association for the Study of the Liver. Brisbane, Australia, March 12Ð15, 2014
F Suzuki,1 K Chayama,2 Y Suzuki,1 K Ikeda,1 J Toyota,3 Y Karino,3 Y Kawakami,2 A Ido,4 K Yamamoto,5 K Takaguchi,6 H Miyagoshi,7 T Eley,8 F McPhee,8 W Hu,8 H Ishikawa,7 EA Hughes,8 H Kumada1
1Toranomon Hospital, Tokyo, Japan; 2Hiroshima University, Hiroshima, Japan; 3Sapporo-Kosei General Hospital, Sapporo, Japan; 4Kagoshima University, Kagoshima, Japan; 5Okayama University, Okayama, Japan; 6Kagawa Prefectural Hospital, Kagawa, Japan; 7Bristol-Myers KK, Tokyo, Japan; 8Bristol-Myers Squibb Research and Development, Princeton, NJ, USA.
![APASL1.gif](../images/031714/031714-2/APASL1.gif)
![APASL2.gif](../images/031714/031714-2/APASL2.gif)
![APASL3.gif](../images/031714/031714-2/APASL3.gif)
![APASL4.gif](../images/031714/031714-2/APASL4.gif)
![APASL5.gif](../images/031714/031714-2/APASL5.gif)
![APASL6.gif](../images/031714/031714-2/APASL6.gif)
![APASL7.gif](../images/031714/031714-2/APASL7.gif)
![APASL8.gif](../images/031714/031714-2/APASL8.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|